On March 8, 2012, the protocol for our planned intern study of MDMA-assisted psychotherapy for PTSD received conditional approval from the Instititional Review Board (IRB) pending a few minor modifications to study documents. The protocol was submitted to the FDA on February 27 and is awaiting review.

This study will take place in Boulder, Colorado, and will explore the effectiveness of MDMA-assisted psychotherapy when one member of the male/female co-therapist team is an experienced therapist and the other is an intern working under supervision for credit towards licensure.
Shared publiclyView activity